A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid Tumors.

Filippo de Braud, Jean-Pascal H. Machiels, Daniela Boggiani, Sylvie W. H. Rottey, Matteo Duca, Marie Laruelle, Stefania Salvagni, Silvia Damian, Lore D. F. Lapeire, Marcello Tiseo, Alexandre Dermine, Mahmoud Ould-Kaci, Juergen Braunger, Juliane Rascher, Daniela Fischer, Josef Hoefler, Gabriella L. Mariani, Sara Cresta

Research output: Contribution to journalArticlepeer-review

Fingerprint Dive into the research topics of 'A Phase 1 Study of mTORC1/2 Inhibitor BI 860585 as a Single Agent or with Exemestane or Paclitaxel in Patients with Advanced Solid Tumors.'. Together they form a unique fingerprint.

Medicine & Life Sciences